Department of Internal Medicine, Hôpital Foch, Suresnes, France.
Department of Respiratory Medicine, Hôpital Foch, Suresnes, France.
Chest. 2020 Dec;158(6):e269-e271. doi: 10.1016/j.chest.2020.06.024.
There is growing evidence that coronavirus disease 2019 (COVID-19) is associated with a hypercoagulable state. To date, all patients reported with venous thromboembolic disease and COVID-19 have shown evidence of viral pneumonia. Here, we report the case of a 31-year-old patient with unexplained extensive DVT and bilateral pulmonary embolism in the absence of COVID-19 pneumonia, leading to the diagnosis of otherwise asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In the context of the COVID-19 pandemic, given the high rates of otherwise asymptomatic patients, testing for SARS-CoV-2 should be performed in all patients with unexplained VTE occurring in COVID-19-endemic areas, even in the absence of other disease manifestations suggestive of SARS-CoV-2 infection.
越来越多的证据表明,2019 年冠状病毒病(COVID-19)与高凝状态有关。迄今为止,所有报告的伴有静脉血栓栓塞疾病和 COVID-19 的患者均显示出病毒性肺炎的证据。在这里,我们报告了一例 31 岁的患者,其患有不明原因的广泛深静脉血栓形成和双侧肺栓塞,而无 COVID-19 肺炎,导致诊断为无症状严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染。在 COVID-19 大流行的背景下,鉴于大量无症状患者,在 COVID-19 流行地区发生不明原因的 VTE 的所有患者中,即使没有其他提示 SARS-CoV-2 感染的疾病表现,也应进行 SARS-CoV-2 检测。